Effects of formaldehyde vapor on the nasal cavity and lungs of F-344 rats. 1996

E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
Division of Risk Assessment, National Institute of Health Sciences, Tokyo, Japan.

Histopathological and biochemical examinations of the nasal cavity and lungs of rats inhaling 145.6 ppm (high-dose) or 15.0 ppm (low-dose) formaldehyde vapor for 6 h revealed dose-related damage. The contents of non-protein SH groups (NPSH) in the nasal mucosa and lung, and lipid peroxide (LPO) in the nasal mucosa were decreased, whereas LPO was increased in the lung. The contents of triglyceride in the lung tissue and lavage, and free cholesterol in the lung were decreased, providing evidence of a suppression of surfactant production. Exposure-related changes in the nasal turbinates, trachea, and lung included hyperkeratosis of the squamous epithelium, increased secretion, and desquamation of ciliated and mucosal cells. Under the present experimental conditions, 145.6 ppm formaldehyde vapor was found to strongly affect the exposed tissues. Changes in lipid peroxide were dependent on the level of exposure.

UI MeSH Term Description Entries
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009296 Nasal Cavity The proximal portion of the respiratory passages on either side of the NASAL SEPTUM. Nasal cavities, extending from the nares to the NASOPHARYNX, are lined with ciliated NASAL MUCOSA. Nasal Cavities,Cavities, Nasal,Cavity, Nasal
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
January 1986, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
April 1983, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
December 1986, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
September 1987, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
February 1986, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
December 1981, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
September 1980, Cancer research,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
November 1984, Toxicology and applied pharmacology,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
March 2008, International journal of environmental research and public health,
E Kamata, and M Nakadate, and O Uchida, and Y Ogawa, and T Kaneko, and Y Kurokawa
January 1990, Journal of toxicology and environmental health,
Copied contents to your clipboard!